Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
SG&A Expense Growth
3.40%
Quarterly · Period ending:
TEVA SG&A Expense Growth
Latest reported3.40%period ending
Latest reported3.40%period ending
TEVA Quarterly SG&A Growth (QoQ) (0.00% → 3.40%)
Latest values, visible window
High-resolution chart · PNG
TEVA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.795% | |
| -4.1914% | |
| 20.0968% | |
| 7.008% | |
| 18.6225% | |
| -10.8815% | |
| 20.9633% | |
| 4.3796% | |
| 3.9848% | |
| -4.3557% | |
| -3.8394% | |
| 17.1779% | |
| 4.4872% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |